Preservation of endurance and mobility during allogeneic hematopoietic cell transplantation (alloHCT)

被引:0
|
作者
Limbach, M. [1 ,2 ]
Wehrle, A. [3 ]
机构
[1] Heidelberg Univ, NCT, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[2] Univ Freiburg, Klin Innere Med 1, Hugstetter Str 55, D-79106 Freiburg, Germany
[3] Univ Freiburg, Inst Bewegungs & Arbeitsmed, Hugstetter Str 55, D-79106 Freiburg, Germany
来源
关键词
allogeneic hematopoietic stem cell transplantation; endurance exercise; balance training; assessment methods;
D O I
10.1055/s-0042-103395
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
As a consequence of alloHCT, various side effects occur which lead to the decline of physical capability. The aim of this randomized pilot study (n = 13) was the preservation of the physical capability through endurance exercise or balance training and to investigate adaption to the new recommendations for assessment methods. Overall, there was a reduction of the physical capability despite therapeutic exercises. Whereas the assessment methods were well tolerated, the toxic therapy and the therapy-induced immobilization seemed to have altered normal cardiovascular und musculoskeletal training adaption and led to the weakness of aerobic capacity.
引用
收藏
页码:45 / 49
页数:5
相关论文
共 50 条
  • [21] Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Extranodal Natural Killer (Nk)/T-Cell Lymphoma, Nasal Type (ENKL): A CIBMTR Analysis
    Kanate, Abraham S.
    Olteanu, Horatiu
    Ahn, Kwang Woo
    DiGilio, Alyssa
    Sureda, Anna
    Fenske, Timothy S.
    Smith, Sonali M.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S38 - S39
  • [22] Impact of geographic distance to patient residence on the outcome of allogeneic hematopoietic cell transplantation (alloHCT) in a JACIE-accreditated transplant center
    Brand, S.
    Dietrich, S.
    Hegenbart, U.
    Bondong, A.
    Luft, T.
    Schoenland, S.
    Ho, A.
    Goerner, M.
    Dreger, P.
    BONE MARROW TRANSPLANTATION, 2015, 50 : 5546 - 5546
  • [23] Studying the Optimal Intravenous Busulfan Exposure in Pediatric Allogeneic Hematopoietic Cell Transplantation (alloHCT) to Improve Clinical Outcomes: A Multicenter Study
    Lalmohamed, Arief
    Bartelink, Imke
    van Reij, Liesbeth
    Dvorak, Christopher C.
    Savic, Rada
    Zwaveling, Juliette
    Bredius, Robbert
    Egberts, Antoine
    Bierings, Marc
    Kletzel, Morris
    Shaw, Peter
    Nath, Christa
    Hempel, Georg
    Ansari, Marc
    Krajinovic, Maja
    Gungor, Tayfun
    Wynn, Robert F.
    Veys, Paul
    Cuvelier, Geoff
    Chiesa, Robert
    Slatter, Mary
    Long-Boyle, Janel
    Boelens, Jaap
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S102 - S103
  • [24] CNS Disease at Diagnosis May Predict Relapse of Hematologic Malignancies in Pediatric Patients After Allogeneic Hematopoietic Cell Transplantation (AlloHCT)
    Shah, Nirali
    Borowitz, Michael J.
    Steinberg, Seth
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather
    Loeb, David
    Wayne, Alan S.
    Chen, Allen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S255 - S256
  • [25] Palliative care during and following allogeneic hematopoietic stem cell transplantation
    Mitchell, Sandra A.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2018, 12 (01) : 58 - 64
  • [26] Kidney Transplantation After Allogeneic Hematopoietic Cell Transplantation
    Ziliotis, Marie -Julia
    Vauchy, Charline
    Deconinck, Eric
    Berceanu, Ana
    Buchler, Mathias
    Caillard, Sophie
    Couzi, Lionel
    Dussol, Bertrand
    Frimat, Luc
    Hazzan, Marc
    Jaulin, Jean -Paul
    Malvezzi, Paolo
    Latour, Regis Peffault de
    Ducloux, Didier
    Courivaud, Cecile
    KIDNEY INTERNATIONAL REPORTS, 2024, 9 (04): : 1127 - 1131
  • [27] Acute myeloid leukemia with FLT3 mutation: a therapeutic window for targeted therapy after allogeneic hematopoietic cell transplantation (alloHCT)
    Esteve, J.
    Labopin, M.
    Brunet, S.
    Schmid, C.
    Poire, X.
    Bazarbachi, A.
    Rocha, V.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S116 - S116
  • [28] Post-Relapse Survival in Lymphoma Patients (Pts) after Experiencing Therapy Failure Following an Allogeneic Hematopoietic Cell Transplantation (alloHCT)
    Epperla, Narendranath
    Kodali, Dheeraj
    Kleman, Ariel
    Hari, Parameswaran
    Pasquini, Marcelo C.
    D'Souza, Anita
    Saber, Wael
    Shah, Nirav
    Fenske, Timothy S.
    Craig, Michael D.
    Kanate, Abraham S.
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S37 - S38
  • [29] Estimating Propensity Scores for the Receipt of Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Outcomes Research Using Claims Data: A Machine Learning Approach
    Vanness, David
    Preussler, Jaime M.
    Burns, Linda J.
    Denzen, Ellen M.
    Leppke, Susan N.
    Majhail, Navneet S.
    Mupfudze, Tatenda
    Saber, Wael
    Silver, Alicia
    Steinert, Patricia
    Mau, Lih-Wen
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S266 - S267
  • [30] Routine Bone Marrow and CSF Analysis Following Allogeneic Hematopoietic Cell Transplantation (AlloHCT) in Children with Leukemia: Lack of Consensus and Questionable Utility
    Levinson, Anya
    Arnold, Staci
    Kung, Andrew
    Bhatia, Monica
    George, Diane
    Garvin, James
    Satwani, Prakash
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S231 - S232